Alpha Cognition (NASDAQ:ACOG – Get Free Report) is expected to be announcing its earnings results before the market opens on Wednesday, April 2nd. Analysts expect the company to announce earnings of ($1.50) per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.
Alpha Cognition Stock Performance
NASDAQ ACOG opened at $5.48 on Wednesday. The firm has a market cap of $87.79 million, a P/E ratio of -2.14 and a beta of 2.50. Alpha Cognition has a 12 month low of $4.66 and a 12 month high of $7.00. The company’s 50-day moving average is $5.88.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright initiated coverage on shares of Alpha Cognition in a research report on Tuesday, March 18th. They set a “buy” rating and a $20.00 price target for the company.
Alpha Cognition Company Profile
Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Featured Stories
- Five stocks we like better than Alpha Cognition
- P/E Ratio Calculation: How to Assess Stocks
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- Compound Interest and Why It Matters When Investing
- NVIDIA Insiders Sell: This Is What It Means for the Market
- About the Markup Calculator
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Alpha Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
